Fresenius SE





Fresenius Medical Care

Fresenius Medical Care is the world's leading provider of products and services for patients with chronic kidney failure. As at December 31, 2007 Fresenius Medical Care treats about 173,863 patients in 2,238 dialysis clinics.

in million €
2007
2006
Change in %
Sales
7,093
6,768
5
- of which contribution to consolidated
sales
7,089
6,763
5
- of which intercompany sales
4
5
-20
- as % of consolidated sales
62 %
63 %
EBITDA
1,418
1,295
9
Depreciation and amortization
265
245
8
EBIT
1,153
1,050
10
Net interest
-271
-280
3
Net income
523
427
22
Operating cash flow
875
723
21
Debt
3,833
4,236
-10
Total assets
9,626
9,905
-3
Capital expenditure
423
372
14
Acquisitions
257
3,531
-93
Research and development expenses
49
41
20
Employees
(per capita on balance sheet date)
64,662
59,996
8
Key figures
- EBITDA margin
20.0 %
19.1 %
- EBIT margin
16.3 %
15.5 %
- ROOA
12.5 %
11.3 %1)

1) 2006 pro forma Renal Care Group without earnings from the divestiture of the dialysis clinics in the USA